Hunter Shkolnik joins Napoli Bern Ripka
This article was originally published in Scrip
Hunter Shkolnik, after serving more than 15 years as a senior partner at Rheingold, Valet, Rheingold, Shkolnik & McCartney, has joined Napoli Bern Ripka, a law firm dealing with claims arising from pharmaceutical product defects among others, as a senior partner. Mr Shkolnik has a background in personal injury cases in the area of drug and medical device product liability.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.